Hepatitis C symptoms are unusually easy to miss. Most people with a new infection feel nothing at all, and many who develop the chronic form live for years before fatigue, itchy skin or an abnormal liver enzyme result finally prompts a blood test. That silence is why the virus is now found far more often through routine screening than through how someone feels. In this article you will learn which signs appear at each stage, how the two-step blood test separates a past infection from a current one, which lab markers doctors use to judge liver damage, and how modern antiviral pills cure the large majority of people in weeks. You will also see what changes after a cure and what does not.
What hepatitis C is, and why it stays quiet for so long
Hepatitis C is an infection of the liver caused by the hepatitis C virus, usually shortened to HCV. The virus enters the bloodstream, reaches the liver and copies itself inside liver cells. The damage that follows comes not from the virus directly, but from the immune system attacking infected cells month after month. That slow, low-grade inflammation is why the liver can lose a lot of healthy tissue before anyone notices a problem.
The liver also has an unusual amount of spare capacity: it keeps filtering blood and making clotting proteins with only a fraction of its tissue working normally. A person can therefore feel entirely well while scarring quietly accumulates.
Acute versus chronic infection
The first six months after exposure are the acute phase. Roughly a quarter to a third of people clear the virus on their own during this window, without treatment. Everyone else moves into chronic infection, meaning the virus is still detectable after six months. Chronic hepatitis C is the form that, over decades, can lead to serious liver disease.
Hepatitis C is not the only virus that inflames the liver, and the three common types behave very differently. A separate guide covers hepatitis A, an acute infection spread through contaminated food and water, and another explains hepatitis B, a bloodborne infection with its own vaccine. Hepatitis C stands apart on two counts: there is no vaccine against it, and it is the one that can be cured with a short course of pills.
Hepatitis C symptoms at each stage
Because the infection unfolds over years, it helps to group hepatitis C symptoms into three stages rather than treat them as a single list.
Early symptoms, in the first weeks
When early symptoms do appear, they usually start two to twelve weeks after exposure and are easy to mistake for a viral illness. The Centers for Disease Control and Prevention lists fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, joint pain, dark urine, clay-colored stools and yellowing of the skin or eyes. Most people have none of these, and when they do occur they fade within a few weeks, which is misleading: feeling better does not mean the virus has gone.
Chronic symptoms, over the years
Long-term infection is often described by patients as a general dimming rather than an illness. The most common complaints are persistent tiredness that sleep does not fix, difficulty concentrating, aching joints and muscles, low mood, mild discomfort under the right ribs, itchy skin without a rash, and bruising more easily than before. None of these point to hepatitis C on their own, which is precisely why testing rather than symptom-spotting finds the infection.
Symptoms of advanced liver disease
The signs that clearly indicate trouble arrive only once significant scarring has developed: jaundice, swelling of the legs and ankles, fluid collecting in the abdomen, vomiting blood or passing black stools, spider-like blood vessels on the chest, and episodes of confusion or unusual drowsiness. Decades of inflammation can produce cirrhosis, the advanced scarring that replaces working liver tissue. Anyone with established cirrhosis needs regular imaging, because scarred tissue can also develop liver cancer.
How the virus spreads, and who should be tested
Hepatitis C travels through blood-to-blood contact. In the United States the dominant route today is shared drug-injecting equipment, including needles, syringes, cookers and rinse water. Other recognized routes include unsterile tattooing or piercing equipment, needlestick injuries at work, transmission from parent to baby during birth, and transfusions or transplants received before donor screening began in 1992. Sexual transmission is possible but uncommon, and the risk rises when blood is involved or when a person also lives with HIV.
Just as important is what does not spread the virus: hugging, kissing, coughing, sneezing, sharing meals or cutlery, and using the same toilet.
Screening recommendations for adults
Because symptoms are such a poor guide, screening is now universal rather than risk-based. The CDC recommends hepatitis C testing at least once for every adult aged 18 and older, testing during each pregnancy, and repeat testing for anyone with ongoing risk, such as current injection drug use or long-term dialysis. The US Preventive Services Task Force makes a comparable recommendation for adults aged 18 to 79. In practice, you do not need a reason or a symptom to ask for the test. Because the same exposures overlap, clinics that offer hepatitis C screening frequently also offer an HIV blood test at the same visit.
The two-step blood test that confirms a current infection
Hepatitis C testing is a sequence, not a single result, and this is where most confusion arises. The first step is the HCV antibody test, which looks for the proteins your immune system made against the virus. Antibodies appear within about eight to eleven weeks of exposure and, in most people, stay in the blood for life. That is the crucial point: the antibody test answers “were you ever infected?”, not “are you infected now?”.
The second step is the HCV RNA test, sometimes called a nucleic acid or viral load test. It looks for the genetic material of the virus itself. RNA is present only when the virus is actively circulating, so this test answers the question that matters for treatment. A laboratory can usually run it on the same sample drawn for the antibody test, a practice known as reflex testing, which spares you a second visit.
| What your two results say | What it usually means | Typical next step |
|---|---|---|
| Antibody not detected | No sign of past or present infection | Nothing further, unless exposure happened in the last few weeks |
| Antibody detected, RNA not detected | You were infected at some point, and the virus is no longer in your blood: it cleared on its own or was cured | No antiviral treatment needed; retest only after a new exposure |
| Antibody detected, RNA detected | Current infection | Referral for antiviral treatment, plus tests to assess liver scarring |
| RNA detected, antibody not detected | Very early infection, before antibodies have formed; also possible when the immune system is weakened | Repeat testing and prompt specialist review |
The second row causes the most worry. A positive antibody with an undetectable RNA result is good news: it is the signature of a cleared infection. The antibodies are a scar left by the immune response, not evidence of ongoing illness, and they are not protective, so they do not shield you from catching hepatitis C again.
Blood markers that show how your liver is coping
Once a current infection is confirmed, the next question is how much damage has already been done. That assessment now relies far more on blood tests and elastography scans than on liver biopsy.
Liver enzymes
Damaged liver cells leak enzymes into the bloodstream. Doctors usually start by reading the liver enzyme ALT, the most liver-specific of the group, and pair it with the AST liver enzyme and its normal range. In chronic hepatitis C these values often bounce between normal and mildly raised, so a single normal reading never rules out infection or scarring. Clinicians follow the pattern across several draws; a companion article walks through the patterns behind high liver enzyme results.
Platelets and the FIB-4 score
A scarred liver raises pressure in the portal vein and enlarges the spleen, which traps platelets and pulls their number down. Hepatologists therefore watch the platelet count closely, because a slow decline over years is one of the earliest quiet clues to advancing fibrosis. That number comes from a complete blood count panel.
Combining these values gives the FIB-4 score, a calculation built from age, AST, ALT and the platelet count that needs no extra blood draw. A low score makes advanced scarring unlikely, a high score triggers further imaging, and a middle score means an elastography scan is needed. FIB-4 is a screening shortcut, not a verdict.
Markers of liver function
Enzymes measure injury; a separate group of markers shows whether the liver is still doing its job. Bilirubin rises when the liver struggles to process the pigment left over from old red blood cells. Albumin, a protein the liver makes, falls when production capacity drops. Prothrombin time and the derived INR lengthen when clotting factors run short. When these shift together, the liver is losing function rather than simply being inflamed.
Treatment with direct-acting antivirals, and what a cure means
The treatment of hepatitis C changed completely in the mid-2010s. The old interferon injections, which took up to a year and caused flu-like misery, have been replaced by direct-acting antivirals: tablets that block specific proteins the virus needs to copy itself. According to the CDC, treatment cures more than 95 percent of people, usually with eight to twelve weeks of pills and usually without significant side effects.
Several current combinations are pan-genotypic, meaning they work against all the main genetic variants of the virus. That has simplified care: for most previously untreated people without cirrhosis, genotype testing is no longer required, and treatment can be prescribed in primary care rather than only by a specialist.
What SVR12 actually means
Cure has a precise definition. Twelve weeks after the last tablet, a repeat HCV RNA test is performed. If the virus is undetectable then, the result is called a sustained virologic response at 12 weeks, written SVR12, and it is accepted as a cure. Relapse afterwards is rare. Your antibody test will stay positive permanently, which is normal and is not a sign of failed treatment.
What a cure changes, and what it does not
Clearing the virus stops ongoing inflammation, mild to moderate fibrosis often improves over the following years, and fatigue frequently lifts. What a cure does not do is undo established cirrhosis. People who reached that stage before treatment still need lifelong monitoring and twice-yearly ultrasound screening, because their liver cancer risk stays elevated even with the virus gone.
A cure also confers no immunity. Because the antibodies your body made are not protective, you can be reinfected through a new blood exposure. Reinfection is diagnosed with an RNA test, never with the antibody test, and it can be treated again with the same class of medicines.
When to see a doctor
Some situations warrant an appointment within days rather than at your next routine visit:
- Yellowing of the skin or the whites of the eyes, dark urine, or pale, clay-colored stools.
- New swelling of the abdomen or of both legs and ankles.
- Vomiting blood, or stools that are black and tarry.
- Confusion, unusual drowsiness or difficulty being woken, in someone with known liver disease.
- A known blood exposure, such as a needlestick injury or shared injecting equipment, which should prompt testing rather than waiting for symptoms.
Book a non-urgent appointment if you have never been screened as an adult, if fatigue has been unexplained for months, if a liver enzyme result came back raised on a routine panel, or if you were once told you tested positive for hepatitis C antibodies but never had an RNA test to check whether the infection is still there.
Latest scientific advances
Research since 2023 has moved on from whether hepatitis C can be cured to two newer questions: how to reach people who are never tested, and how to look after those already cured.
Clearer guidance on what happens after a cure
A 2024 position paper from the European Association for the Study of the Liver set out how people should be followed once the virus is gone. Its core message is that follow-up depends on how much scarring existed before treatment: people with little or no fibrosis can generally return to ordinary care, while those with advanced scarring need continued surveillance for liver cancer. What this means for you: after a cure, the question to ask your doctor is not “am I still infected?” but “how much scarring did I have, and what follow-up does that earn me?”.
Cure does not protect against catching it again
A long-term follow-up of the HERO study, published in 2024, tracked people who inject drugs for up to three and a half years after cure. A meaningful minority became infected again, and the rate varied widely between clinics. What this means for you: the antibodies left by an old infection are a record, not a shield. After a new blood exposure, ask specifically for an RNA test, since the antibody test stays positive regardless. This was an observational study, meaning researchers followed participants rather than assigning them to groups, so it describes one population rather than proving a cause.
A second course of treatment usually works
A 2025 analysis from the same research programme looked at people who were retreated, either because the first course did not clear the virus or because they were reinfected. Nearly all of those who started a second course and had a result available were cured. What this means for you: a treatment that does not work the first time is not a dead end. The harder problem, the researchers noted, was that fewer than half of those eligible actually began retreatment, which is a question of access rather than of whether the medicines work.
Shorter courses are being tested for very early infection
A trial reported in 2026, called PURGE-C, gave just four weeks of a combination antiviral to people whose hepatitis C had been picked up very recently. Roughly eight in ten were cured, and everyone retreated after the short course went on to be cured. What this means for you: four weeks is not yet standard care, and eight to twelve weeks remains the recommended course. This was a single-arm trial, meaning there was no comparison group, and the numbers were small, so the finding is promising but preliminary.
Simpler testing methods reach more people
A 2026 systematic review, which pools results from many separate studies, examined ways to improve testing and treatment in prisons, where hepatitis C is far more common than in the general population. The approaches with the strongest evidence were the simplest ones, particularly dried blood spot testing, which uses a few drops from a finger prick instead of a venous draw. What this means for you: the direction of travel is fewer visits between a first test and a first tablet, which is also why reflex RNA testing is becoming routine.
Glossary
| Term | Definition |
|---|---|
| HCV | Hepatitis C virus, the virus that causes the infection. It spreads through blood-to-blood contact. |
| HCV antibody test | A blood test that detects the proteins your immune system made against the virus. It shows past exposure and usually stays positive for life. |
| HCV RNA test | A blood test that detects the virus’s own genetic material. It is the test that confirms whether an infection is present right now. |
| Reflex testing | A laboratory practice of automatically running the RNA test on the same sample when the antibody test is positive, so no second blood draw is needed. |
| Direct-acting antivirals | Tablets that block proteins the hepatitis C virus needs in order to copy itself. They are the current standard treatment. |
| Pan-genotypic | Describes a treatment that works against all the main genetic variants of the virus, which removes the need for genotype testing in most cases. |
| SVR12 | Sustained virologic response at 12 weeks: no virus detectable in the blood twelve weeks after the last tablet. This is the accepted definition of cure. |
| Fibrosis | Scar tissue that gradually replaces healthy liver tissue when inflammation continues for years. |
| FIB-4 score | A calculation combining age, two liver enzymes and the platelet count to estimate how likely advanced scarring is, without any extra blood test. |
| Cirrhosis | The advanced stage of scarring, in which the liver’s structure is permanently altered and its function starts to decline. |
Frequently asked questions
Can hepatitis C be passed on through saliva, kissing or sharing food?
No. Hepatitis C needs blood-to-blood contact to spread. Saliva, sweat, tears, sharing meals, sharing cutlery or glasses, hugging, kissing, coughing and sneezing do not transmit the virus, and neither does using the same toilet. The realistic household precaution is not to share anything that might carry traces of blood, which in practice means razors, toothbrushes, nail clippers and glucose-testing lancets. Everyday contact with someone who has hepatitis C carries no risk, and there is no reason to keep separate dishes or laundry.
Are hepatitis C symptoms different in women and men?
The infection itself behaves the same way, and the core symptoms are identical: fatigue, joint aches, nausea, itchy skin and, in advanced disease, jaundice. Research suggests women are somewhat more likely to clear the virus naturally during the acute phase, and that scarring tends to progress more slowly before menopause, though this difference narrows afterwards. Fatigue and joint pain are also reported more often by women, which can make the picture harder to disentangle from other common conditions. None of this changes the testing pathway or the treatment, which are the same regardless of sex.
What are the signs that hepatitis C is getting worse?
Progression is usually silent, and lab results tend to shift before symptoms do: a slowly falling platelet count, a rising FIB-4 score, or bilirubin and INR drifting upward. The symptoms that do signal worsening liver disease are jaundice, abdominal swelling, leg swelling, easy bruising or bleeding, and episodes of confusion. Because the early changes are invisible, monitoring is based on scheduled blood tests and elastography scans rather than on how you feel. Report any of the symptoms above promptly rather than waiting for the next appointment.
Am I still contagious after successful treatment?
Once you have a confirmed SVR12, meaning no detectable virus twelve weeks after finishing treatment, you are no longer infectious. You cannot pass hepatitis C to anyone else through blood contact, and there is no need for special precautions. Your antibody test will remain positive for life, which sometimes causes confusion with blood donation services or insurers, so it helps to keep a copy of the RNA result that documented your cure. Being cured does not protect you from a future infection through a new blood exposure.
Is there a vaccine for hepatitis C?
Not yet. The virus mutates quickly and exists as many genetic variants, which has made vaccine development considerably harder than it was for hepatitis A and hepatitis B, both of which do have vaccines. Research continues, but no hepatitis C vaccine is approved anywhere. Prevention therefore rests on avoiding blood exposure and on testing, and doctors often recommend that people living with hepatitis C be vaccinated against hepatitis A and hepatitis B, so that the liver is not dealing with more than one infection at once.
What do the stages of hepatitis C mean?
Two different scales are often mixed up. The first describes the infection: acute in the first six months, then chronic if the virus is still present after that. The second describes the liver, and grades scarring from none through mild and moderate fibrosis to cirrhosis. A person can have chronic infection with no scarring at all, which is common when the infection is found early. Your treatment is the same regardless of stage, but the amount of scarring determines how closely you are followed afterwards.
Sources
- Centers for Disease Control and Prevention — Hepatitis C Basics, 2025 — cdc.gov/hepatitis-c/about
- MedlinePlus, National Library of Medicine — Hepatitis C, 2025 — medlineplus.gov/hepatitisc.html
- Mayo Clinic — Hepatitis C: symptoms and causes, 2025 — mayoclinic.org, hepatitis C symptoms and causes
- Reiberger T, Lens S, Cabibbo G, et al. — EASL position paper on clinical follow-up after HCV cure — Journal of Hepatology, 2024 — pubmed.ncbi.nlm.nih.gov/38845253
- Litwin AH, Tsui JI, Heo M, et al. — Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study — JAMA Network Open, 2024 — pubmed.ncbi.nlm.nih.gov/39186268
- Thomas AM, Litwin AH, Tsui JI, et al. — Retreatment of Hepatitis C Virus Among People Who Inject Drugs — Clinical Infectious Diseases, 2025 — pubmed.ncbi.nlm.nih.gov/40230037
- Kim AY, Kang M, Umbleja T, et al. — Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C — Clinical Infectious Diseases, 2026 — pubmed.ncbi.nlm.nih.gov/40736252
- Cunningham EB, Wheeler A, Hajarizadeh B, et al. — Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis — International Journal of Drug Policy, 2026 — pubmed.ncbi.nlm.nih.gov/41494919
Further reading
- Total bilirubin and what your levels mean
- Albumin, the protein your liver makes
- Prothrombin time and blood clotting speed
- Reference ranges, flags and next steps on a lab report
- Abnormal blood test results in someone who feels fine
Understand your lab results with BloodSense
Hepatitis C is a condition that lives almost entirely in your lab report rather than in how you feel, which makes those numbers worth understanding. BloodSense reads your results in plain language and shows how markers such as the HCV antibody and RNA tests, ALT and AST, the platelet count and bilirubin fit together over time. It helps you understand what you are looking at and prepare better questions for your appointment. It does not diagnose, and it does not replace your doctor.
